Perakizumab, being studied by Novan, presents a exciting step in the treatment against various scarring diseases. Unlike current therapies, this molecule specifically targets blocks the beta-TGF signaling, a critical https://kobifrft084824.activoblog.com/52368911/perakizumab-a-potential-treatment-for-fibrosis-conditions